Literature DB >> 3981951

Non-Hodgkin's lymphomas presenting with gastrointestinal involvement.

W Siegert, G Hackl, U Löhrs, D Huhn.   

Abstract

Between 1978 and 1983 a total of 33 patients with non-Hodgkin's lymphoma (NHL) involving the gastrointestinal tract were seen in our institution. Pathological classification was performed according to Kiel. Low grade NHL was diagnosed in 17, high grade NHL in 16 patients. The most frequent histological entity was lymphoplasmocytoid immunocytoma (11 patients). The most common sites of origin were the stomach (23 patients) and the ileocecal region (6 patients). The majority of patients presented with stage I and II disease (20 of 33 patients). As a rule primary therapy consisted of surgery with curative intent. Most of the patients received additional chemotherapy or radiotherapy. Patients with limited disease and complete tumour resection showed long-term survival from 12+ to 57+ months (mean 32.9+ months). Patients with advanced disease (stage III and IV) and only palliative surgery or with lymphoblastic lymphoma had a probability of survival of less than 12 months.

Entities:  

Mesh:

Year:  1985        PMID: 3981951     DOI: 10.1007/bf01733068

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  25 in total

1.  Systematic re-staging in the management of non-Hodgkin's lymphomas.

Authors:  T S Herman; S E Jones
Journal:  Cancer Treat Rep       Date:  1977-09

2.  Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone.

Authors:  C M Bagley; V T Devita; C W Berard; G P Canellos
Journal:  Ann Intern Med       Date:  1972-02       Impact factor: 25.391

3.  A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas.

Authors:  N I Nissen; J Ersbøll; H S Hansen; S Walbom-Jørgensen; J Pedersen-Bjergaard; M M Hansen; J Rygård
Journal:  Cancer       Date:  1983-07-01       Impact factor: 6.860

4.  A new working formulation of non-Hodgkin's lymphomas. A retrospective study of the new NCI classification proposal in comparison to the Rappaport and Kiel classifications.

Authors:  G R Krueger; J R Medina; H O Klein; A Konrads; J Zach; M Rister; G Janik; K G Evers; T Hirano; H Kitamura; V A Bedoya
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

5.  Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy.

Authors:  R I Fisher; V T DeVita; B L Johnson; R Simon; R C Young
Journal:  Am J Med       Date:  1977-08       Impact factor: 4.965

6.  Extranodal non-Hodgkin's lymphoma.

Authors:  S Reddy; E Pellettiere; V Saxena; F R Hendrickson
Journal:  Cancer       Date:  1980-11-01       Impact factor: 6.860

7.  Occurrence and prognosis of extranodal lymphomas.

Authors:  C Freeman; J W Berg; S J Cutler
Journal:  Cancer       Date:  1972-01       Impact factor: 6.860

8.  Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.

Authors:  R I Fisher; V T DeVita; S M Hubbard; D L Longo; R Wesley; B A Chabner; R C Young
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

9.  Primary gastric lymphomas. A clinicopathologic study of 58 cases with long-term follow-up and literature review.

Authors:  J J Brooks; H T Enterline
Journal:  Cancer       Date:  1983-02-15       Impact factor: 6.860

10.  The role of surgery in the management of gastric lymphoma.

Authors:  I D Fleming; S Mitchell; R A Dilawari
Journal:  Cancer       Date:  1982-03-15       Impact factor: 6.860

View more
  1 in total

1.  Combined surgery and chemotherapy for the treatment of primary gastrointestinal intermediate- or high-grade non-Hodgkin's lymphomas.

Authors:  G Bellesi; R Alterini; A Messori; A Bosi; F Bernardi; S di Lollo; P R Ferrini
Journal:  Br J Cancer       Date:  1989-08       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.